Dr. Sumati V. Gupta
Claim this profileHuntsman Cancer Institute/University of Utah
Studies Bladder Cancer
Studies Cancer
7 reported clinical trials
29 drugs studied
Area of expertise
1Bladder Cancer
Stage IV
Stage III
ARID1A positive
2Cancer
Stage IV
Stage III
ARID1A positive
Affiliated Hospitals
Clinical Trials Sumati V. Gupta is currently running
Standard Therapy + Surgery/Radiation
for Prostate Cancer
This phase III trial studies how well standard systemic therapy with or without definitive treatment (prostate removal surgery or radiation therapy) works in treating participants with prostate cancer that has spread to other places in the body. Addition of prostate removal surgery or radiation therapy to standard systemic therapy for prostate cancer may lower the chance of the cancer growing or spreading.
Recruiting2 awards Phase 330 criteria
Immunotherapy With or Without Surgery
for Kidney Cancer
This phase III trial compares the effect of adding surgery to a standard of care immunotherapy-based drug combination versus a standard of care immunotherapy-based drug combination alone in treating patients with kidney cancer that has spread to other places in the body (metastatic). Immunotherapy with monoclonal antibodies, such as nivolumab, ipilimumab, pembrolizumab, and avelumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Axitinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Surgery to remove the kidney, called a nephrectomy, is also considered standard of care; however, doctors who treat kidney cancer do not agree on its benefits. It is not yet known if the addition of surgery to an immunotherapy-based drug combination works better than an immunotherapy-based drug combination alone in treating patients with kidney cancer.
Recruiting2 awards Phase 316 criteria
More about Sumati V. Gupta
Clinical Trial Related5 years of experience running clinical trials · Led 7 trials as a Principal Investigator · 4 Active Clinical TrialsTreatments Sumati V. Gupta has experience with
- Nivolumab
- Tucatinib
- Trastuzumab
- Fulvestrant
- Durvalumab
- Belinostat
Breakdown of trials Sumati V. Gupta has run
Bladder Cancer
Cancer
Transitional Cell Carcinoma
Urothelial Carcinoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Sumati V. Gupta specialize in?
Sumati V. Gupta focuses on Bladder Cancer and Cancer. In particular, much of their work with Bladder Cancer has involved Stage IV patients, or patients who are Stage III.
Is Sumati V. Gupta currently recruiting for clinical trials?
Yes, Sumati V. Gupta is currently recruiting for 4 clinical trials in Salt Lake City Utah. If you're interested in participating, you should apply.
Are there any treatments that Sumati V. Gupta has studied deeply?
Yes, Sumati V. Gupta has studied treatments such as Nivolumab, Tucatinib, Trastuzumab.
What is the best way to schedule an appointment with Sumati V. Gupta?
Apply for one of the trials that Sumati V. Gupta is conducting.
What is the office address of Sumati V. Gupta?
The office of Sumati V. Gupta is located at: Huntsman Cancer Institute/University of Utah, Salt Lake City, Utah 84112 United States. This is the address for their practice at the Huntsman Cancer Institute/University of Utah.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.